<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The barrier function of the glomerular filter has been studied for decades </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0002871'>Albuminuria</z:mp> reflects a malfunction of this barrier, and in animals dysfunctional endothelial nitric-<z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) synthase results in <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We aimed to analyze the importance of NO for the glomerular barrier function in humans </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: To assess the effect of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> on <z:mp ids='MP_0002871'>albuminuria</z:mp>, we measured the urine albumin-to-<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio (UACR) both before and after the blockade of NO synthases (NOSs) with systemic infusion of N(G)-monomethyl-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (<z:chebi fb="0" ids="28229">L-NMMA</z:chebi>) in two distinct study populations </plain></SENT>
<SENT sid="4" pm="."><plain>In population A, 62 hypertensive patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and, in population B, 22 patients with <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> but without <z:hpo ids='HP_0000822'>hypertension</z:hpo> or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were examined </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> subjects had <z:mpath ids='MPATH_458'>normal</z:mpath> renal function </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: There was a significant increase in the UACR in response to NOS inhibition with <z:chebi fb="0" ids="28229">L-NMMA</z:chebi> in hypertensive patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (study population A) and in patients with <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> (study population B) </plain></SENT>
<SENT sid="7" pm="."><plain>Linear regression analyses revealed that the change in mean arterial presssure in response to <z:chebi fb="0" ids="28229">L-NMMA</z:chebi> was not related to the increase in the UACR in response to <z:chebi fb="0" ids="28229">L-NMMA</z:chebi> in either population, even after adjusting for filtration fraction </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: NOS inhibition provokes <z:mp ids='MP_0002871'>albuminuria</z:mp> that is unrelated to changes in blood pressure </plain></SENT>
<SENT sid="9" pm="."><plain>It is noteworthy that this finding was evident in patient groups prone to <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> and <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, <z:hpo ids='HP_0011009'>acute</z:hpo> deterioration of endothelial function by reducing NO activity causes an increase in <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
</text></document>